Evidence Mandating Earlier and More Aggressive Treatment of Hypercholesterolemia
Author:
Affiliation:
1. From the Department of Medicine, University of California San Diego, La Jolla.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Link
https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.107.753152
Reference75 articles.
1. Steinberg D. The Cholesterol Wars: The Cholesterol Skeptics vs the Preponderance of Evidence. New York NY: Academic Press/Elsevier Inc; 2007.
2. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
3. The Forgotten Majority
Cited by 86 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Safety and efficacy of PCSK9 inhibitor (evolocumab) in patients with non-ST segment elevation acute coronary syndrome and non-culprit artery critical lesions: a randomised controlled trial protocol (SPECIAL study);BMJ Open;2024-07
2. Effect of L-arginine on myocardial vascular atherosclerosis in rabbits under high mountain environment;BIO Web of Conferences;2024
3. Lipid Profile in Olympic Athletes: Proposal for a “Lipid Athlete Score” as a Clinical Tool to Identify High-Risk Athletes;Journal of Clinical Medicine;2023-11-30
4. Endometriosis promotes atherosclerosis in a murine model;American Journal of Obstetrics and Gynecology;2022-08
5. Anti dyslipidemic effect of Ficus Carica Fruit (Fig) on Lipid Profile of Diet Induced Hyperlipidemic Rats;Pakistan Journal of Medical and Health Sciences;2021-07-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3